Autres langues Xenon Pharmaceuticals Inc.

Actions

XENE

CA98420N1050

Temps réel estimé Cboe BZX Autres places de cotation 15:30:49 16/07/2024			Varia. 5j.	Varia. 1 janv.
42,4 ^USD	+1,21 %		+12,66 %	-9,03 %

12/06	Transcript : Xenon Pharmaceuticals Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 04:00 PM
04/06	Transcript : Xenon Pharmaceuticals Inc. - Shareholder/Analyst Call

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	05/06
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting	28/05
Xenon Pharmaceuticals Inc. Presents Data from Phase 2 X-Nova Clinical Trial of Azetukalner in Major Depressive Disorder At the American Society of Clinical Psychopharmacology 2024 Annual Meeting	28/05
Encephalopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	21/05
Xenon Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Xenon Pharmaceuticals Q1 Net Loss Narrows	09/05
Xenon Pharmaceuticals: Q1 Earnings Snapshot	09/05
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update	09/05
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update	09/05
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024	08/05
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference	07/05
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update	02/05
Xenon Pharmaceuticals Inc. Announces Board Resignations	19/04
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting	16/04
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	10/04
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	04/04
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days	12/03
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days	12/03
Xenon Pharmaceuticals Insider Sold Shares Worth $330,290, According to a Recent SEC Filing	08/03
Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing	08/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Xenon Pharmaceuticals Inc.

Actions

XENE

CA98420N1050

Autres langues

Filtres